Prevalence of Schizophrenia Spectrum and Bipolar Disorder Among Cannabis Induced Psychosis Patients
Cannabis induced psychosis risk prevalence clinical insights reveal that a significant portion of patients develop schizophrenia spectrum or bipolar disorder. Early identification and monitoring are essential for managing this risk. Understanding…
Endocannabinoid System Research: Cannabis in HIV Care
Digital therapeutics HIV smoking cessation research shows strong feasibility and acceptability among people living with HIV. This approach offers scalable cessation tools for this high-risk population. Tobacco use remains a leading cause of illness and…
Cannabidiol for Lennox-Gastaut: Cannabinoid Clinical Trials
Clinically meaningful reduction in drop seizures has been observed in Lennox-Gastaut syndrome patients treated with cannabidiol. Clinical trials show that even reductions below 50% can improve patient quality of life. Caregiver-reported outcomes align…
Cannabinoid Clinical Trials: CBD Gel Safety in Fragile X
Transdermal cannabidiol gel fragile x syndrome safety data comes from ongoing clinical trials evaluating long-term tolerability in children and adolescents. This synthetic CBD formulation targets behavioral symptoms linked to endocannabinoid…
Cannabinoid Clinical Trials: CBD, WADA, and Urine Testing Insights
Broad-spectrum CBD supplements doping risk is a critical concern for athletes subject to anti-doping rules. This study found that daily use of broad-spectrum CBD can produce detectable WADA-prohibited cannabinoids in urine. Exercise further amplifies…
Cannabidiol Clinical Trials: CBD, Psychosis Risk & Brain
Cannabidiol clinical trials high risk psychosis research show that a single dose of CBD influences hippocampal glutamate levels and prefrontal brain activation. This modulation may affect memory processing pathways disrupted in early psychosis. These…
Topical Cannabis for AIMSS: Cannabinoid Clinical Trials
Topical cannabis balms for AIMSS were tested in a randomized trial for breast cancer patients experiencing joint pain from aromatase inhibitor therapy. The study assessed feasibility and safety of cannabinoid topical treatments. Results provide early…
Cannabinoid Clinical Trials: Cannabis Effects on Alcohol Urge
Working memory cannabis alcohol urge interactions reveal how cognitive capacity affects alcohol cravings after cannabis use. This clinical trial shows that individuals with higher working memory capacity experience reduced alcohol urge. These findings…
Review of Cannabis Derivatives in Autism Clinical Research
Cannabis derivatives autism clinical research shows preliminary benefits for symptoms like irritability and sleep difficulties. The evidence remains limited and requires cautious interpretation. Patients should consult clinicians before considering…
Endocannabinoid System Research: Cannabis & Teen Mental Health
This study highlights internalising symptoms adolescent cannabis use risk, showing that anxiety and depression symptoms predict cannabis initiation. Adolescents with these symptoms are more likely to use cannabis frequently. Understanding this risk can…